Gapping up
In reaction to earnings/guidance:
- JELD +5.2%, MSEX +5%, NOMD +4.5%, CNA +0.8%
Other news:
- LLAP +46.9% (received a $100 mln investment from Lockheed Martin (LMT) in exchange for convertible notes and warrants issued by Terran Orbital)
- ATNM +7.9% (top-line results from pivotal phase 3 SIERRA trial of Iomab-B in patients with active relapsed or refractory acute myeloid leukemia)
- ADMA +1.8% (FDA approval for its seventh ADMA BioCenters plasma collection facility located in Greensboro, North Carolina)
- LXU +1.6% (announces increase to stock repurchase authorization)
Analyst comments:
- BMRN +1.7% (upgraded to Outperform from Perform at Oppenheimer)